Community Diversity Health equity Equity Diversity and Inclusion
A light rain began to patter on the yellowing fall leaves as, one by one, dozens of people – many in white lab coats and green scrubs – lay down on concrete benches or the grass. Others sat with their heads bowed, as if to meditate, or pray, or ponder the pain and injustice that had brought them there.
Community Health equity Advancement
Revised blood donation rules that do away with a rule that defers men who have sex with men (MSM) to abstain from sex for three months prior to donating blood are beginning to be implemented into blood banks throughout the country.
Research Health equity Artificial Intelligence (AI)
The discussion around bias in artificial intelligence (AI) is no longer contained to data. Even the most impartial algorithm or analysis can encounter prejudice.
Research Health equity Artificial Intelligence (AI)
Chatbots are increasingly becoming a part of health care around the world, but do they encourage bias? That’s what University of Colorado School of Medicine researchers are asking as they dig into patients’ experiences with the artificial intelligence (AI) programs that simulate conversation.
Community Diversity Health equity
Representation matters.
On a recent day in her pediatric pulmonary clinic, the first patient Jennifer Taylor-Cousar, MD, saw was a 10-year-old girl who is Black and who asked if she could keep the disposable gloves and stethoscope used during her appointment. She wants to be a doctor, just like Taylor-Cousar.
CPR
July 25, 2024
In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.
9News
July 23, 2024
A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.
Healthy Debate
July 18, 2024
In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.
Medscape
July 18, 2024
Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.
Mark Harden
